Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

OMEGA THERAPEUTICS, INC.

(OMGA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Omega Therapeutics : Falls in Nasdaq Debut After Pricing IPO at Midpoint of Expected Range

07/30/2021 | 01:52pm EDT


ę MT Newswires 2021
All news about OMEGA THERAPEUTICS, INC.
09/10OMEGA THERAPEUTICS' : Q2 Loss Widens as Operating Expenses Rise
MT
09/10OMEGA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
09/10OMEGA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
09/10OMEGA THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Outlines Key Corpor..
PR
09/10Omega Therapeutics, Inc. Announces Unaudited Earnings Results for the Second Quarter an..
CI
08/24OMEGA THERAPEUTICS : Jefferies Starts Omega Therapeutics at Buy With $30 Price Target
MT
08/24OMEGA THERAPEUTICS : Goldman Sachs Starts Omega Therapeutics at Neutral With $22 Price Tar..
MT
08/24OMEGA THERAPEUTICS : Piper Sandler Starts Omega Therapeutics at Overweight With $30 Price ..
MT
08/24OMEGA THERAPEUTICS : Wedbush Starts Omega Therapeutics at Outperform With $36 Price Target
MT
08/03OMEGA THERAPEUTICS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year..
AQ
More news
Analyst Recommendations on OMEGA THERAPEUTICS, INC.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -82,4 M - -
Net cash 2021 206 M - -
P/E ratio 2021 -8,23x
Yield 2021 -
Capitalization 951 M 951 M -
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees -
Free-Float 96,4%
Chart OMEGA THERAPEUTICS, INC.
Duration : Period :
Omega Therapeutics, Inc. Technical Analysis Chart | OMGA | US68217N1054 | MarketScreener
Technical analysis trends OMEGA THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 19,91 $
Average target price 29,50 $
Spread / Average Target 48,2%
EPS Revisions
Managers and Directors
Mahesh Karande President, Chief Executive Officer & Director
Roger A. Sawhney Chief Financial Officer
Noubar B. Afeyan Chairman
Thomas McCauley Chief Scientific Officer
Mary T. Szela Director
Sector and Competitors
1st jan.Capi. (M$)
OMEGA THERAPEUTICS, INC.0.00%951
MODERNA, INC.305.22%170 876
LONZA GROUP AG31.58%59 927
IQVIA HOLDINGS INC.41.30%48 510
CELLTRION, INC.-23.26%31 691
SEAGEN INC.-9.18%28 939